Trump Nominates Pro-Life Doctor to be Next FDA Chief

The nomination comes as the FDA is currently conducting a much-anticipated safety review of the abortion drug mifepristone.

Pro-Life Advocates Increase Pressure on FDA to Conduct Abortion Pill Review: FDA Head Responds

Pro-life leaders increased pressure on the FDA in relation to its review of the abortion pill mifepristone following a report suggesting that FDA Commissioner Dr. Marty Makary told officials to delay the review until after the midterm elections. Makary has denied the allegations.

Tagged abortion pillFDA reviewMarty Makarymifepristone